Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 29, 2012
Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis modelFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
The American Journal of Gastroenterology|January 28, 2010
A practical guide to vaccinating the inflammatory bowel disease patientSharmeel K Wasan, Stacey E Baker, Paul R Skolnik, et al.
Pharmaceutics|November 22, 2017
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug DeliveryMunawar A Mohammed, Jaweria T M Syeda, Kishor M Wasan, et al.
Gastrointestinal Endoscopy|April 19, 2015
Female authorship in major academic gastroenterology journals: a look over 20 yearsMichelle T Long, Ania Leszczynski, Katherine D Thompson, et al.
International Journal of Pharmaceutics|July 10, 2012
Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasisFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
Drug Development and Industrial Pharmacy|June 16, 2010
Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and SudanSheila J Thornton, Kishor M Wasan, Anna Piecuch, et al.
Advanced Drug Delivery Reviews|December 7, 2007
Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infectionsKristina Sachs-Barrable, Stephen D Lee, Ellen K Wasan, et al.
Crohn'S & Colitis 360|February 13, 2023
The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With VedolizumabJill E Harrington, Rachel E Hamilton, Lisa Ganley-Leal, et al.
Inflammatory Bowel Diseases|April 9, 2016
Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose ImmunosuppressionSharmeel K Wasan, Samantha Zullow, Adam Berg, et al.
International Journal of Pharmaceutics|June 28, 2002
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cellsEllen K Wasan, Dawn Waterhouse, Olena Sivak, et al.
Pageof 7